These studies definitively established that pathogenic variants in eight canonical genes, including BRCA1, BRCA2, PALB2, BARD1, RAD51C, RAD51D, ATM, and CHEK2, demonstrate significant association with increased breast cancer susceptibility. This evidence concerns the gene RAD51C and breast carcinoma.